O

    Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC)

    Official site

    FINANCIAL SERVICES • SHELL COMPANIES • NASDAQ

    $10.76
    +0.02 (+0.19%)

    Market Cap: $264.02M

    Last updated: Aug 31, 2026 at 5:00 PM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    		$0.07N/AN/ABeat-18.4%
    Mar 26
    		$0.06N/AN/ABeat-19.0%
    Dec 25
    		$0.07N/AN/ABeat+29.8%
    Sep 25
    		$0.08N/AN/ABeat+900.0%
    Jun 25
    		$0.08N/AN/ABeat-
    Mar 25
    		$0.07N/AN/ABeat-
    Dec 24
    		$0.06N/AN/ABeat-
    Sep 24
    		$-0.01$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio39.16EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE0.00%ROIC12.67%
    Financial Health
    Debt/Equity-0.00xInterest CoverageN/A
    Current Ratio0.73xQuick Ratio0.73x
    Trading Statistics
    BetaN/AAvg Volume12.95K
    52-Week High$10.8852-Week Low$10.36

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$10.76
    SMA 20$10.76
    SMA 50$10.72
    SMA 200$10.66
    EMA 10$10.76
    EMA 20$10.75
    EMA 50$10.73
    EMA 200$10.64

    MACD

    Line: 0.01Signal: 0.01Hist: -0.00

    ADX

    ADX: 48.6+DI: 31.9-DI: 29.5

    Aroon & PSAR

    Aroon Up12.0
    Aroon Down4.0
    PSAR$10.84

    Bollinger Bands

    Upper Band$10.81
    Lower Band$10.71
    %B Position87%(Upper)
    Band Width0.52

    RSI (14-Day)

    Neutral
    53.6

    Momentum Oscillators

    Stoch %K48.8
    Stoch %D58.7
    Williams %R-50.0
    ROC (10d)-0.4%
    Momentum-0.04
    CCI (20d)-1.5
    MFI (14d)58.2

    Volatility Measures

    ATR (14d)$0.02(0.2%)
    StdDev (20d)0.02
    Hist Vol2.9%(Low)

    Volume Flow

    VWAP$10.76
    OBV7.5M
    AD Line143.1K
    CMF (20d)-0.557

    Volume Metrics

    Avg Vol (20d)13.6K
    Vol Ratio4.1x(High)
    VWMA (20d)$10.74

    Pivot Points

    R3$10.87
    R2$10.83
    R1$10.79
    Pivot Point$10.75
    S1$10.71
    S2$10.67
    S3$10.63

    Advanced Oscillators

    TSI14.80
    Ultimate Osc41.9
    KST3.67

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
    Total Revenue$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0N/A$0$0$0N/A$0
    Gross Profit$0$0N/A$0$0$0N/A$0
    Operating Expenses$261,958$456,538$255,496$225,579$269,810$444,802$303,711$48,095
    R&D$0$0$0$0$0$0$0$0
    SG&A$261,958$456,538$255,496$225,579$269,810$444,802$303,711$48,095
    Operating Income$-261,958$-456,538$-255,496$-225,579$-269,810$-444,802$-303,711$-48,095
    Interest Income$1.87M$1.85M$2.04M$2.19M$2.14M$2.10M$0$0
    Interest Expense$0$0$0$0$0$0$0$0
    Income Before Tax$1.60M$1.39M$1.79M$1.97M$1.87M$1.66M$1.38M$-48,095
    Income Tax Expense$0$0$0$0$0$0$0$0
    Net Income$1.60M$1.39M$1.79M$1.97M$1.87M$1.66M$1.38M$-48,095
    EBITDA$-261,958$-456,538$-255,496$-225,579$-269,810$-444,802$-303,711$-48,095
    EBIT$-261,958$-456,538$-255,496$-225,579$-269,810$-444,802N/A$-48,095
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OACC

    News

    Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (NASDAQ: OACC) Stock Price, News & Analysis

    This article provides an overview of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (NASDAQ: OACC), including its current stock price, fundamental data, and a disclaimer about the information provided. As of the last update, OACC was trading at $10.80, up 0.37%. The piece highlights various financial metrics and directs users to further research and news.

    Kalkine•8/13/26•
    Neutral

    Oaktree Acquisition Corp. III Life Sciences Reports Q2 2026 Financial Results in SEC 10-Q Filing

    Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) has filed its Q2 2026 financial results with the SEC, reporting a net income of $1,604,621 for the quarter ended June 30, 2026. This figure is a decrease from $1,874,343 in Q2 2025. The company's Trust Account balance increased to $205,280,770, and the redemption value per share for Class A ordinary shares rose to $10.69.

    Kalkine Media•8/12/26•
    Neutral

    Oaktree Acquisition Corp. III Life Sciences (OACC) posts $3.0M H1 2026 income

    Oaktree Acquisition Corp. III Life Sciences (OACC), a SPAC, reported a net income of $1.6 million for Q2 2026 and $3.0 million for H1 2026, primarily from interest on its $205.3 million Trust Account. The company faces a critical deadline of October 25, 2026, to complete a business combination, with management expressing substantial doubt about its ability to continue as a going concern due to expected costs and limited working capital.

    Stock Titan•8/12/26•
    Bearish

    Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Sees Large Decline in Short Interest

    Short interest in Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) declined significantly in June, dropping 57.9% to 12,043 shares. The company, a SPAC sponsored by Oaktree Capital Management focusing on the life sciences sector, currently has a "Sell" consensus rating from analysts, with Weiss Ratings reiterating a "sell (d)" rating. Despite the decline in short interest, the stock traded near its 12-month high at $10.72, though with below-average trading volume.

    MarketBeat•7/15/26•
    Somewhat-Bearish

    Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Trading 0.2% Higher - What's Next?

    Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) saw its shares increase by 0.2% on Friday, trading at $10.7140 with very light volume. Despite this slight increase, the sentiment for the stock remains weak, with Weiss Ratings reaffirming a "sell (d)" rating and MarketBeat's average analyst rating being "Sell." Several institutional investors have adjusted their positions in the company, with some increasing their stakes while none initiated new significant positions.

    MarketBeat•7/11/26•
    Somewhat-Bearish

    Frequently Asked Questions About OACC

    Does OACC pay dividends?
    Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) does not currently pay a regular dividend.
    What is OACC's P/E ratio?
    Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share has a price-to-earnings (P/E) ratio of 39.16.
    What is OACC's market cap?
    Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) has a market capitalization of $264.02M with a current stock price of $10.76.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In